Epigenetic drugs, such as DNMT inhibitors (e.g., decitabine) and HDAC inhibitors (e.g., vorinostat), have been tested in glioblastoma and pediatric brain tumor trials and are under investigation for MB [28,79,80]. The gene discussed is HDAC9; the disease is brain neoplasm.